From: Practical approach to COVID-19: an Egyptian pediatric consensus
Discharge standards | Medication after discharge | Follow-up plan |
---|---|---|
1- Body temperature: normal for > 3 days. 2- Respiratory symptoms: significantly improved. 3- PCR: negative for respiratory tract pathogen twice (48 h apart). 4- Lung imaging: showing obvious improvement. 5- No comorbidities or complications which require hospitalization. 6- SpO2, > 94% without assisted oxygen inhalation. 7- Discharge approved by multi-disciplinary medical team. | Symptomatic Treatment: as needed Antiviral drugs: for patients with multiple lung lesions in the first 3 days after their nucleic acid tests are negative. | Follow-up call: within 48 h after discharge. Outpatient follow-up: 1 week, 2 weeks after discharge. Examinations: include • CBC&CRP • Lung CT scan according to the patient's condition. • PCR test of sputum and stool samples. • Liver and kidney functions, Follow-up phone calls: 3 and 6 months after discharge. |